Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Neuroscience
    September 2022
  1. ZHAI Z, Xie D, Qin T, Zhong Y, et al
    Effect and Mechanism of Exogenous Melatonin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic review and Meta-analysis.
    Neuroscience. 2022 Sep 15. pii: S0306-4522(22)00466.
    >> Share

    August 2022
  2. TORRES-FLORES M, Pena-Ortega F
    Amyloid Beta Alters Prefrontal-dependent Functions Along with its Excitability and Synaptic Plasticity in Male Rats.
    Neuroscience. 2022;498:260-279.
    >> Share

  3. UNGERLEIDER K, Beck JA, Lissa D, Joruiz S, et al
    Delta133p53alpha Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity.
    Neuroscience. 2022;498:190-202.
    >> Share

  4. BIANCHIN MM, Snow Z
    Primary Microglia Dysfunction or Microgliopathy: A Cause of Dementias and Other Neurological or Psychiatric Disorders.
    Neuroscience. 2022;497:324-339.
    >> Share

  5. PATTA PC, de Oliveira EMN, Goulart ACF, Zaluski AB, et al
    Nanoscale Structural Characterization and Impact on Long-term memory of Amyloid-beta42 Oligomeric forms in Zebrafish.
    Neuroscience. 2022;497:271-281.
    >> Share

  6. ZHU Y, Gao M, Huang H, Gao SH, et al
    p75NTR Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye Movement Sleep Deprivation Mice Model.
    Neuroscience. 2022;496:27-37.
    >> Share

    June 2022
  7. WU Y, Wu X, Gao L, Yan Y, et al
    Abnormal functional connectivity of thalamic subdivisions in alzheimer's disease: A functional magnetic resonance imaging study.
    Neuroscience. 2022 Jun 8. pii: S0306-4522(22)00291.
    >> Share

    May 2022
  8. GUZMAN-RAMOS K, Osorio-Gomez D, Bermudez-Rattoni F
    Cognitive impairment in alzheimer's and metabolic diseases: A catecholaminergic hypothesis.
    Neuroscience. 2022 May 30. pii: S0306-4522(22)00271.
    >> Share

  9. LIANG F, Sun F, He B, Wang J, et al
    Treadmill Exercise Promotes Microglial beta-Amyloid Clearance and Prevents Cognitive Decline in APP/PS1 Mice.
    Neuroscience. 2022;491:122-133.
    >> Share

  10. QU W, Canoll P, Hargus G
    Molecular insights into cell type-specific roles in alzheimer's disease: human induced pluripotent stem cell-based disease modeling.
    Neuroscience. 2022 May 12. pii: S0306-4522(22)00235.
    >> Share

    April 2022
  11. ZHANG F, Pan B, Shao P, Liu P, et al
    A Single Model Deep Learning Approach for Alzheimer's Disease Diagnosis.
    Neuroscience. 2022 Apr 7. pii: S0306-4522(22)00149.
    >> Share

    February 2022
  12. CLARK I
    Basic Scientific Evidence Consistent with Etanercept Efficacy Against Alzheimer's Disease.
    Neuroscience. 2022;484:139.
    >> Share

  13. MACKENZIE JL, Ivanova N, Nell HJ, Giordano CR, et al
    Microglial inflammation and cognitive dysfunction in comorbid rat models of striatal ischemic stroke and alzheimer's disease: effects of antioxidant catalase-SKL on behavioral and cellular pathology.
    Neuroscience. 2022 Feb 3. pii: S0306-4522(22)00047.
    >> Share

    January 2022
  14. ASIH PR, Stefanoska K, Prikas E, Ittner A, et al
    High level forebrain expression of active tau kinase p38gamma exacerbates cognitive dysfunction in aged APP-transgenic alzheimer's mice.
    Neuroscience. 2022 Jan 11. pii: S0306-4522(22)00012.
    >> Share

  15. HORTA-LOPEZ PH, Mendoza-Franco G, Rodriguez-Cruz F, Torres-Cruz FM, et al
    Association of alpha-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain.
    Neuroscience. 2022 Jan 8. pii: S0306-4522(22)00002.
    >> Share

    December 2021
  16. HAN H, Li X, Gan JQ, Yu H, et al
    Biomarkers derived from alterations in overlapping community structure of resting-state brain functional networks for detecting Alzheimer's disease.
    Neuroscience. 2021 Dec 29. pii: S0306-4522(21)00662.
    >> Share

  17. LI Y, Fan H, Ni M, Zhang W, et al
    Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-kappaB Pathways in Alzheimer's Disease: An In Vitro and In Vivo Investigation.
    Neuroscience. 2021 Dec 22. pii: S0306-4522(21)00551.
    >> Share

  18. AHMADI A, Gispert JD, Navarro A, Vilor-Tejedor N, et al
    Single-cell Transcriptional Changes in Neurodegenerative Diseases.
    Neuroscience. 2021;479:192-205.
    >> Share

    November 2021
  19. DUNCAN MJ, Guerriero LE, Kohler K, Beechem LE, et al
    Chronic fragmentation of the daily sleep-wake rhythm increases amyloid-beta levels and neuroinflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Neuroscience. 2021 Nov 29. pii: S0306-4522(21)00609.
    >> Share

  20. CHINNATHAMBI S, Gorantla NV
    Implications of Valosin-containing Protein in Promoting Autophagy to Prevent Tau Aggregation.
    Neuroscience. 2021;476:125-134.
    >> Share

    August 2021
  21. ZHANG W, Xiong BR, Zhang LQ, Huang X, et al
    The Role of the GABAergic System in Diseases of the Central Nervous System.
    Neuroscience. 2021;470:88-99.
    >> Share

    June 2021
  22. MANSOUR HM, Fawzy HM, El-Khatib AS, Khattab MM, et al
    Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer's Disease: Current Perspectives and Challenging Prospects.
    Neuroscience. 2021 Jun 15. pii: S0306-4522(21)00305.
    >> Share

    May 2021
  23. ALBUS A, Kronimus Y, Neumann S, Vidovic N, et al
    Effects of a Multimerized Recombinant Autoantibody Against Amyloid-beta.
    Neuroscience. 2021;463:355-369.
    >> Share

  24. GUIX FX
    Enhancing Anti-Abeta Properties of Recombinant Autoantibodies.
    Neuroscience. 2021;463:354.
    >> Share

    April 2021
  25. JUNG H, Yi D, Soo Byun M, Ho Lee J, et al
    Functional Neural Correlates of the WAIS-IV Block Design Test in Older Adult with Mild Cognitive Impairment and Alzheimer's Disease.
    Neuroscience. 2021 Apr 15. pii: S0306-4522(21)00179.
    >> Share

  26. NAZANIN HAJJARI S, Sadigh-Eteghad S, Shanehbandi D, Teimourian S, et al
    MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer's disease.
    Neuroscience. 2021 Apr 6. pii: S0306-4522(21)00163.
    >> Share

    March 2021
  27. ZENG L, Zhang D, Liu Q, Zhang J, et al
    Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Abeta42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus.
    Neuroscience. 2021;458:141-152.
    >> Share

  28. LEDEZMA C, Coria-Lucero C, Delsouc MB, Casais M, et al
    Effect of an Intracerebroventricular Injection of Aggregated Beta-amyloid (1-42) on Daily Rhythms of Oxidative Stress Parameters in the Prefrontal Cortex.
    Neuroscience. 2021;458:99-107.
    >> Share

    February 2021
  29. WALKER CK, Greathouse KM, Boros BD, Poovey EH, et al
    Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
    Neuroscience. 2021;455:195-211.
    >> Share

  30. CHEN WP, Zhang G, Cheng ZJ, Gu XH, et al
    Corrigendum to "Inhibitor Kappa B Kinase beta, Modulated by DJ-1/p-VHL, Reduces Phosphorylated Tau (p-Tau) Accumulation via Autophagy in Alzheimer's Disease Model" [Neuroscience 452C (2021) 1-12].
    Neuroscience. 2021 Feb 5. pii: S0306-4522(21)00014.
    >> Share

  31. MONTEIRO-FERNANDES D, Sousa N, Almeida OFX, Sotiropoulos I, et al
    Sex Hormone Depletion Augments Glucocorticoid Induction of Tau Hyperphosphorylation in Male Rat Brain.
    Neuroscience. 2021;454:140-150.
    >> Share

    January 2021
  32. MEHMOOD A, Yang S, Feng Z, Wang M, et al
    A Transfer Learning Approach for Early Diagnosis of Alzheimer's Disease on MRI Images.
    Neuroscience. 2021 Jan 16. pii: S0306-4522(21)00007.
    >> Share

  33. PEAK SL, Gracia L, Lora G, Jinwal UK, et al
    Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1.
    Neuroscience. 2021;453:312-323.
    >> Share

    November 2020
  34. AVILA J, Perry G
    A multilevel view of the development of Alzheimer's Disease.
    Neuroscience. 2020 Nov 24. pii: S0306-4522(20)30731.
    >> Share

  35. DOBRI AM, Dudau M, Enciu AM, Hinescu ME, et al
    CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting.
    Neuroscience. 2020 Nov 17. pii: S0306-4522(20)30719.
    >> Share

  36. LUO Y, Sun T, Ma C, Zhang X, et al
    Alterations of Brain Networks in Alzheimer's Disease and Mild Cognitive Impairment: A Resting State fMRI Study Based on a Population-specific Brain Template.
    Neuroscience. 2020 Nov 13. pii: S0306-4522(20)30684.
    >> Share

  37. ZHOU Y, Ge Y, Liu Q, Li YX, et al
    LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
    Neuroscience. 2020 Nov 13. pii: S0306-4522(20)30688.
    >> Share

    October 2020
  38. CHEN WP, Zhang G, Cheng ZJ, Gu XH, et al
    IKKbeta, modulated by DJ-1/p-VHL, reduces phosphorylated Tau (p-Tau) accumulation via autophagy in Alzheimer's disease model.
    Neuroscience. 2020 Oct 15. pii: S0306-4522(20)30656.
    >> Share

    September 2020
  39. DAS R, Chinnathambi S
    Actin-mediated microglial chemotaxis via G-protein coupled Purinergic receptor in Alzheimer's disease.
    Neuroscience. 2020 Sep 14. pii: S0306-4522(20)30597.
    >> Share

  40. MASMUDI-MARTIN M, Navarro-Lobato I, Lopez-Aranda MF, Browning PGF, et al
    Reversal of object recognition memory deficit in perirhinal cortex-lesioned rats and primates and in rodent models of aging and alzheimers diseases.
    Neuroscience. 2020 Sep 6. pii: S0306-4522(20)30564.
    >> Share

    June 2020
  41. ZHU Z, Zhang L, Cui Y, Li M, et al
    Functional compensation and mechanism of choline acetyltransferase in the treatment of cognitive deficits in aged dementia mice.
    Neuroscience. 2020 Jun 1. pii: S0306-4522(20)30313.
    >> Share

    May 2020
  42. ROSAS-HERNANDEZ H, Cuevas E, Raymick JB, Robinson BL, et al
    Impaired amyloid beta clearance and brain microvascular dysfunction are present in the Tg-SwDI mouse model of Alzheimer's disease.
    Neuroscience. 2020 May 22. pii: S0306-4522(20)30321.
    >> Share

    April 2020
  43. CHIDAMBARAM H, Chinnathambi S
    G-Protein coupled receptors and tau-different roles in alzheimer's disease.
    Neuroscience. 2020 Apr 23. pii: S0306-4522(20)30241.
    >> Share

    March 2020
  44. MALLOZZI C, Crestini A, D'Amore C, Piscopo P, et al
    Activation of tyrosine phosphorylation signaling in erythrocytes of patients with alzheimer's disease.
    Neuroscience. 2020 Mar 7. pii: S0306-4522(20)30143.
    >> Share

  45. LI F, Xie XY, Sui XF, Wang P, et al
    Profile of pathogenic proteins and microRNAs in plasma-derived extracellular vesicles in Alzheimer's disease: A pilot study.
    Neuroscience. 2020 Mar 2. pii: S0306-4522(20)30137.
    >> Share

    February 2020
  46. ALVES VS, Arcisio-Miranda M, Carrettiero DC, Oliveira FA, et al
    Transport of glucose by the plasma membrane affects the removal and concentration of Ca(2+) at rest in neurons - Implications of a condition prior to Alzheimer's disease?
    Neuroscience. 2020 Feb 11. pii: S0306-4522(20)30078.
    >> Share

    January 2020
  47. MA K, Yu J, Shao W, Xu X, et al
    Functional Overlaps Exist in Neurological and Psychiatric Disorders: A Proof from Brain Network Analysis.
    Neuroscience. 2020;425:39-48.
    >> Share

  48. MA X, Zhuo Z, Wei L, Ma Z, et al
    Erratum to 'Altered Temporal Organization of Brief Spontaneous Brain Activities in Patients with Alzheimer's Disease' [Neuroscience 425C (2020) 1-11].
    Neuroscience. 2020 Jan 11. pii: S0306-4522(20)30001.
    >> Share

  49. WHYTE LS, Hassiotis S, Hattersley KJ, Hemsley KM, et al
    Lysosomal dysregulation in the murine App(NL-G-F/NL-G-F) model of Alzheimer's disease.
    Neuroscience. 2020 Jan 6. pii: S0306-4522(19)30897.
    >> Share

    November 2019
  50. MA X, Zhuo Z, Wei L, Ma Z, et al
    Altered Temporal Organization of Brief Spontaneous Brain Activities in Patients with Alzheimer's Disease.
    Neuroscience. 2019 Nov 27. pii: S0306-4522(19)30801.
    >> Share

  51. VON RUDEN EL, Zellinger C, Gedon J, Walker A, et al
    Regulation of Alzheimer's disease-associated proteins during the course of epileptogenesis: differential proteomic analysis in a rat model.
    Neuroscience. 2019 Nov 6. pii: S0306-4522(19)30612.
    >> Share

  52. BAMFORD RA, Widagdo J, Takamura N, Eve M, et al
    The Interaction Between Contactin and Amyloid Precursor Protein and Its Role in Alzheimer's Disease.
    Neuroscience. 2019 Nov 6. pii: S0306-4522(19)30692.
    >> Share

  53. CHATTERJEE M, Teunissen C
    Contactins & Alzheimer's disease Synaptic proteins, contactins may contribute to the pathology of Alzheimer's disease.
    Neuroscience. 2019 Nov 1. pii: S0306-4522(19)30741.
    >> Share

  54. VOSOUGHI A, Sadigh-Eteghad S, Ghorbani M, Shahmorad S, et al
    Mathematical Models to Shed Light on Amyloid-Beta and Tau Protein Dependent Pathologies in Alzheimer's Disease.
    Neuroscience. 2019 Nov 1. pii: S0306-4522(19)30662.
    >> Share

    October 2019
  55. FRAGA VG, Magalhaes CA, de Mello Gomide Loures C, de Souza LC, et al
    Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease.
    Neuroscience. 2019 Oct 22. pii: S0306-4522(19)30653.
    >> Share

    August 2019
  56. AFREEN S, Ferreira A
    Altered Cytoskeletal Composition and Delayed Neurite Elongation in tau45-230-Expressing Hippocampal Neurons.
    Neuroscience. 2019;412:1-15.
    >> Share

    June 2019
  57. STUART KE, King AE, King NE, Collins JM, et al
    Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice.
    Neuroscience. 2019;408:282-292.
    >> Share

    May 2019
  58. PAOLICELLI RC, Bergamini G, Rajendran L
    Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia.
    Neuroscience. 2019;405:148-157.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016